USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
The Liposome Company, Inc.
Address:
One Research Way, Princeton Fo
Rrestal Center
Princeton, NJ 08540
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $47,990.00 1

Award List:

WE PROPOSE TO DEVELOP A GENTAMICIN LIPOSOME-CONTROLLED RELEASE FORMULATION SUITABLE FOR TOPICAL TREATMENT OF BACTERIAL KERATITIS AND CONJUNCTIVITIS THAT PROVIDES EFFICACY AND SAFETY EQUAL TO OR BETTER THAN PRESENT THERAPY AND WHICH REQUIRES FEWER DOSES.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$47,990.00
Agency:
HHS
Principal Investigator:
Michael v.w. bergamini , PRINCIPAL INVESTIGATOR
Abstract:
We propose to develop a gentamicin liposome-controlled release formulation suitable for topical treatment of bacterial keratitis and conjunctivitis that provides efficacy and safety equal to or better than present therapy and which requires fewer doses. in phase i we will increase entrapment of… More